title: [The effects of atorvastatin on aging kidney].
abstract: OBJECTIVE
  To evaluate whether taking atorvastatin for long time has positive effects on age-related renal impairment.
  
  
  METHODS
  20-month-age normal female Wistar rats were divided into three groups (n = 9). First group were fed atorvastatin 10 mg/(kg x d). Second group were fed atorvastatin 1 mg/(kg x d). Third group were fed the same volume normal saline served as control. All the rats were sacrificed after four months. 3-month-age normal female Wistar rats (n = 9) also served as normal control. Kidney weight, serum creatinine (Scr) and blood-lipoids were measured. Paraffin sections of renal tissues were stained with PAS and Sirius red. Sclerosis index of glomerulus was calculated.
  
  
  RESULTS
  Renal mass diminution was found in all the groups of aging rats. Scr was decreased in the group of aging rats with atorvastatin 1 mg/(kg x d). The level of blood-lipoids of aging rats was higher than that of young rats. The level of serum cholesterol and low-density lipoprotein (LDL) were decreased in first group (both P < 0.05) and only LDL decreased in second group (P < 0.05). Morphological changes of aging kidney were focal segmental glomerulosclerosis, widen of mesangial region, infiltration of inflammatory cells and sclerosis of arteriole. The treatment of atorvastatin improved the pathologic changes in the aging rats significantly, especially in the first group.
  
  
  CONCLUSIONS
  Taking atorvastatin for long time can notably improve the pathological changes of aging kidney. All these effects may be induced by lowing of blood-lipoids, relieving the sclerosis of renal arteriole and reducing the infiltration of inflammatory cells.
authors.affiliation: Department of Geriatric Nephrology, General Hospital of PLA, Beijing 100853, China.
authors.forename: Jia-Hui
authors.initials: JH
authors.lastname: Zhao
authors.forename: Qing-Li
authors.initials: QL
authors.lastname: Cheng
authors.forename: Ping
authors.initials: P
authors.lastname: Ye
mesh_terms: D000375:Aging / Q000502:physiology*; D000818:Animals; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000494:pharmacology; D001161:Arteriosclerosis / Q000473:pathology / Q000517:prevention & control*; D000069059:Atorvastatin; D005260:Female; D006538:Heptanoic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D007668:Kidney / Q000473:pathology*; D007674:Kidney Diseases / Q000517:prevention & control; D011758:Pyrroles / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D012077:Renal Artery / Q000473:pathology*
chemical_list: D000924:Anticholesteremic Agents; D006538:Heptanoic Acids; D011758:Pyrroles; D000069059:Atorvastatin